Cargando…
Extended pain relief trial utilizing infiltration of Exparel(®), a long-acting multivesicular liposome formulation of bupivacaine: a Phase IV health economic trial in adult patients undergoing open colectomy
BACKGROUND: The majority of surgical patients experience significant levels of pain after a procedure. While opioid analgesics have been a mainstay of postsurgical analgesic regimens, recent evidence has supported the use of multimodal therapy as a way to decrease opioid usage with its concomitant o...
Autor principal: | Cohen, Stephen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508659/ https://www.ncbi.nlm.nih.gov/pubmed/23204866 http://dx.doi.org/10.2147/JPR.S38621 |
Ejemplares similares
-
An extended paIn relief trial utilizing the infiltration of a long-acting Multivesicular liPosome foRmulation Of bupiVacaine, EXPAREL (IMPROVE): a Phase IV health economic trial in adult patients undergoing ileostomy reversal
por: Marcet, Jorge E, et al.
Publicado: (2013) -
Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial
por: Vogel, Jon D
Publicado: (2013) -
The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs
por: Richard, Brigitte M., et al.
Publicado: (2012) -
EXPAREL® (Long-Acting Liposomal Bupivacaine) Use for Popliteal Nerve Block in Postoperative Pain Control after Ankle Fracture Fixation
por: Discepola, Patrick, et al.
Publicado: (2020) -
Liposomal bupivacaine: a review of a new bupivacaine formulation
por: Chahar, Praveen, et al.
Publicado: (2012)